Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00740857 · ClinicalTrials.gov registry record · Phase 4
Study Comparing the Efficacy of Two Ibuprofen Formulations
A Phase 4 study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 211
- Enrollment target
NCT00740857 is a Phase 4 study that has completed, run by Wyeth is now a wholly owned subsidiary of Pfizer. The registered enrollment target is 211 participants.
The verdict
NCT00740857, a Phase 4 study, has completed, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 211 participants
- Enrollment target
Study Summary
This is a study of healthy volunteers to compare how quickly different ibuprofen products relieve dental pain.
Interventions
- DRUG placebo
- DRUG ibuprofen Formulation 1
- DRUG ibuprofen Formulation 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2008-08 |
| Est. Completion | 2008-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00740857
The ClinicalTrials.gov registry entry for NCT00740857 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00740857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00740857 about?
NCT00740857 is a clinical study titled "Study Comparing the Efficacy of Two Ibuprofen Formulations". This is a study of healthy volunteers to compare how quickly different ibuprofen products relieve dental pain.
What is the current status of trial NCT00740857?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 211 participants. The study started on 2008-08. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00740857?
The interventions under investigation include: placebo (DRUG), ibuprofen Formulation 1 (DRUG), ibuprofen Formulation 2 (DRUG).
Who is sponsoring clinical trial NCT00740857?
This trial is sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.